The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|13|5|681-691

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.5, 2015-09, pp. : 681-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder: A Systematic Review and Exploratory Meta-Analysis

By > Yu Weiping Detraux Johan Sweers Kim > Correll Christoph U.

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 733-759

Adis International

Access to resources Recommend Favorite

Iloperidone, asenapine and lurasidone: a primer on their current status

By Tarazi Frank I Stahl Stephen M

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1911-1922

Informa Healthcare

Access to resources Recommend Favorite

The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania

By Tarazi Frank I Neill Jo C

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 93-103

Informa Healthcare

Access to resources Recommend Favorite

Pirlindole in the Treatment of Depression: A Meta-Analysis

By Macedo Ana

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 61-71

Adis International

Access to resources Recommend Favorite

Aripiprazole in the Treatment of Schizophrenia: A Consensus Report produced by Schizophrenia Experts in Italy

By Cassano Giovan B.

Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. : 1-13

Adis International

Access to resources Recommend Favorite